5/20/26 16:07 | 5/18/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.d | 57 | 3.79 | 0 | 15 | 4 | 362 | D | | | | | | | | | | | | | | |
5/20/26 16:07 | 5/18/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.d | -301 | 20.04 | 0 | -15 | -4 | 362 | D | | | | | | | | | | | | | | |
4/20/26 19:27 | 4/16/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.dm | 160 | 4.24 | 0 | 38 | 12 | 362 | D | | | | | | | | | | | | | | |
4/20/26 19:27 | 4/20/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.d | -354 | 23.61 | 0 | -15 | -4 | 362 | D | | | | | | | | | | | | | | |
3/20/26 17:02 | 3/18/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.dm | 57 | 3.79 | 0 | 15 | 5 | 339 | D | | | | | | | | | | | | | | |
3/20/26 17:02 | 3/18/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.dm | -282 | 18.82 | 0 | -15 | -4 | 339 | D | | | | | | | | | | | | | | |
3/11/26 16:47 | 3/9/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.d | 139 | 3.79 | 0 | 37 | 12 | 339 | D | | | | | | | | | | | | | | |
3/11/26 16:47 | 3/9/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.d | -705 | 19.17 | 0 | -37 | -10 | 339 | D | | | | | | | | | | | | | | |
3/6/26 19:27 | 3/4/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.dm | 31 | 3.79 | 0 | 8 | 2 | 339 | D | | | | | | | | | | | | | | |
3/6/26 19:27 | 3/4/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.dm | -154 | 18.74 | 0 | -8 | -2 | 339 | D | | | | | | | | | | | | | | |
12/18/25 18:02 | 12/16/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.d | 161 | 5.45 | 0 | 30 | 10 | 339 | D | | | | | | | | | | | | | | |
11/25/25 18:40 | 11/24/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.d | 156 | 3.79 | 0 | 41 | 15 | 310 | D | | | | | | | | | | | | | | |
11/25/25 18:40 | 11/24/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.d | -776 | 18.86 | 0 | -41 | -12 | 310 | D | | | | | | | | | | | | | | |
10/20/25 16:11 | 10/16/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.d | 91 | 3.79 | 0 | 24 | 8 | 310 | D | | | | | | | | | | | | | | |
10/20/25 16:11 | 10/16/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.d | -454 | 18.83 | 0 | -24 | -7 | 310 | D | | | | | | | | | | | | | | |
10/15/25 18:00 | 10/13/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.dm | 94 | 3.79 | 0 | 25 | 9 | 310 | D | | | | | | | | | | | | | | |
10/15/25 18:00 | 10/13/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.dm | -467 | 18.88 | 0 | -25 | -7 | 310 | D | | | | | | | | | | | | | | |